NASDAQ$RXST
Rxsight Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
RxSight reported strong revenue growth driven by increased sales of LDDs and LALs.
RxSight, Inc. reported a significant increase in revenue for the second quarter of 2022, driven by strong demand for its Light Delivery Devices (LDD) and Light Adjustable Lenses (LAL). The company's revenue grew by 132% compared to the same quarter last year. The company has revised its 2022 full year revenue guidance to a range of $44.0 million to $46.0 million.
- Revenue for Q2 2022 was $11.4 million, a 132% increase compared to Q2 2021.
- 49 Light Delivery Devices (LDDs) were sold, a 96% unit increase from Q2 2021, expanding the installed base to 294 LDDs.
- 5,400 Light Adjustable Lenses (LALs) were sold, a 196% increase in procedure volumes compared to Q2 2021.
- Full-year 2022 revenue guidance was increased to a range of $44.0 million to $46.0 million.
Headline financials
Revenue & EPS history
Rxsight · Revenue · Quarterly
$11.4M
Revenue by segment
Rxsight · $11.4M total across 2 segments · Q2 2022
- LAL Revenue$5.8M—50.9%
- LDD Revenue$5.6M—49.1%
Forward guidance
RxSight has revised its 2022 full year revenue guidance to a range of $44.0 million to $46.0 million. The revised guidance range implies an annual growth rate versus 2021 of 95% to 104%.
Tailwinds
- Revised 2022 full year revenue guidance to a range of $44.0 million to $46.0 million.
- The revised guidance range implies an annual growth rate versus 2021 of 95% to 104%.
- Increased 2022 gross margin guidance range to 37% to 38% of revenue, up from the previous range of 35% to 36% of revenue.
Headwinds
- Narrowed operating expense guidance to a range of $88.0 million to $90.0 million compared to prior guidance of $86.0 million to $90.0 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2022
-1.1%
Avg return
Earnings day
-2.6%
Avg return
5 days after
+2.8%
Avg return
30 days after
45%
9 / 20 earnings
Positive
+15.1%
Q3 2022
Best reaction
-16.1%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.6% | -21.6% | -31.1% | |
| Q4 2025 | -10.1% | -13.5% | -28.9% | |
| Q3 2025 | +8.7% | +16.3% | +46.7% | |
| Q1 2025 | -11.2% | -11.4% | +0.9% | |
| Q4 2024 | -0.8% | -7.8% | -9.1% | |
| Q3 2024 | -12.3% | -16.9% | -21.2% | |
| Q2 2024 | +14.6% | +21.5% | +29.0% | |
| Q1 2024 | +0.8% | -3.8% | -5.0% | |
| Q4 2023 | -5.8% | -3.2% | -10.9% | |
| Q3 2023 | +1.8% | +9.5% | +40.8% | |
| Q2 2023 | -1.5% | -6.3% | -1.8% | |
| Q1 2023 | +9.0% | +18.3% | +34.0% | |
| Q4 2022 | +9.7% | +4.5% | +17.9% | |
| Q3 2022 | +15.1% | +14.6% | +18.1% | |
| Q2 2022 | -2.9% | -8.3% | -13.3% | |
| Q1 2022 | -4.3% | -3.0% | +34.9% | |
| Q4 2021 | +1.4% | -3.2% | +1.8% | |
| Q3 2021 | +3.7% | -0.8% | -4.0% | |
| Q4 2020 | -16.1% | -18.4% | -21.1% | |
| Q2 2021 | -16.1% | -18.4% | -21.1% | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro